Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NEXI NexImmune > Detailed Quotes

NEXI NexImmune

0.555
-0.003-0.54%
Close 09/30 16:00 ET
0.513
-0.042-7.59%
Post Mkt Price 09/30 19:59 ET
High
0.590
Open
0.580
Turnover
117.83K
Low
0.555
Pre Close
0.558
Volume
206.23K
Market Cap
13.40M
P/E(TTM)
Loss
52wk High
15.410
Shares
24.16M
P/E(Static)
Loss
52wk Low
0.510
Float Cap
9.67M
Bid/Ask %
44.44%
Historical High
28.000
Shs Float
17.43M
Volume Ratio
0.44
Historical Low
0.510
Dividend TTM
--
Div Yield TTM
--
P/B
0.24
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.18%
Amplitude
6.34%
Avg Price
0.571
Lot Size
1
Float Cap
9.67M
Bid/Ask %
44.44%
Historical High
28.000
Shs Float
17.43M
Volume Ratio
0.44
Historical Low
0.510
Dividend TTM
--
P/B
0.24
Dividend LFY
--
Turnover Ratio
1.18%
Amplitude
6.34%
Avg Price
0.571
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
NexImmune, Inc. engages in the development of novel approach to immunotheraphy designed to create therapies with curative potential for patients with cancer and other life threatening immune-mediated diseases. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke in June 7, 2011 and is headquartered in Gaithersburg, MD.
CEO: Ms. Kristi Jones
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...